Start by asking whether an MDT is actually offered
An MDT is a meeting where clinicians from more than one specialty review the same case together. For testicular cancer, that could mean urology, medical oncology, radiation oncology, pathology and radiology. But the format is not guaranteed at every hospital, and it is not something a patient can assume is standard. The first question is administrative, not clinical: does this hospital run an MDT for testicular cancer, how often, and who takes part?
Ask for the answer in writing before you plan travel. A hospital may review cases in a tumour board, a joint clinic, or a weekly meeting with a different name. It may also review records remotely before you arrive, or only after you are registered as a patient. Those are different processes, and they affect what you need to send and when.
If the hospital does not offer an MDT, that does not mean care is unavailable. It means the case may be handled by one lead specialist who refers to colleagues as needed. You can still ask which specialties have been consulted and whether their opinions are documented. The point is to know the format before you rely on it.
What the pathology and marker records need to answer
Testicular cancer care depends heavily on what the tissue and blood tests show. An MDT discussion should answer whether the pathology report is complete enough to classify the tumour, whether any outside slides need review, and whether the marker results are available in a form the treating team can compare over time. If the pathology report is a summary rather than a full report, the discussion may be limited.
The practical question is not 'do you have my records' but 'which specific documents are missing, and can the discussion proceed without them?' Ask the hospital to list what it needs: the original pathology report, the slides or blocks if review is planned, imaging reports and images, and dated marker results. If a document is unavailable, ask whether the team will note that limitation or wait.
Marker records matter because they are usually interpreted as a series, not a single number. Ask whether the hospital wants the raw values with dates and units, and whether it will repeat any tests locally. Do not assume that sending a summary is enough. A records-based opinion is not the same as a full clinical assessment, and the treating team decides what is sufficient.
Previous cancer care and what has already been done
If you have already had surgery, chemotherapy or radiotherapy, the MDT needs to know exactly what was done, when, and with what result. This is not just history-taking. It changes what options remain and what risks are relevant. Ask the hospital to confirm which treatment summaries it needs: operation notes, discharge summaries, drug names and cycles, radiotherapy fields and doses, and the response recorded after each stage.
A common gap is that patients send the most recent report but not the earlier ones. The MDT may then be unable to tell whether a finding is new or stable. Ask whether the team wants a chronological summary you can prepare, or whether it prefers original documents. If you are unsure what matters, ask the hospital to specify the time period it needs covered.
The MDT should also answer what it cannot conclude from the records. If a scan was done elsewhere and the images are not available, the discussion may be provisional. Ask whether the team will state its level of confidence and what further information would change the plan. That is more useful than a general opinion.
Fertility and hormone questions belong in the discussion
Fertility and hormone questions belong in the discussion, and they are not side issues to raise later. An MDT discussion should answer whether fertility preservation has been discussed, what options are available before further treatment, and whether a referral to a reproductive specialist is needed. If you have not had this conversation, ask for it to be included.
The exact risk depends on the individual treatment plan, which the treating team must assess. Do not rely on general statements. Ask what the proposed plan means for your situation, what monitoring is recommended, and whether sperm banking or hormone replacement should be arranged before treatment starts. These are clinical decisions, not administrative ones.
If the hospital does not provide fertility services directly, ask how it refers patients and whether that referral can be arranged before treatment. The answer may affect timing. Raise it early rather than after treatment has begun.
Ask the MDT to state, in the written response, whether fertility preservation has been addressed and what the next step is. If the answer is that it has not been discussed, ask when it will be, and who will lead that conversation. A records-based review can flag the question, but the treating team must assess your individual situation and the options that fit it.
For a patient who has not yet started treatment, the timing of a fertility referral matters because it may need to happen before further treatment begins. For a patient who has already had treatment, the question shifts to what monitoring or referral is appropriate now. Either way, the MDT should answer what it can conclude from the records and what still needs an in-person assessment.
Write the fertility question into your list of items for the MDT, alongside the pathology and marker questions. That way it is answered in the same written response rather than raised separately later. If the hospital cannot answer it, ask which clinician or service can, and whether that referral can be arranged before you travel.
Further treatment: what the MDT should decide and what it cannot
Surgery to remove the affected testicle is a main treatment for testicular cancer, and further care depends on the individual findings. The MDT discussion should answer whether additional treatment is recommended, what the alternatives are, and what the plan is if the first approach does not work. It should also state what is still uncertain and what test or review would resolve that uncertainty.
Ask the hospital to distinguish between a recommendation and a decision. A records-based review may suggest a direction, but it does not establish final eligibility for a procedure or confirm that a treatment is available at that hospital. The treating team makes those decisions after seeing you and any required tests. If you are told a plan is 'confirmed' before you arrive, ask what still needs to be verified in person.
For a complex case, a multidisciplinary review involving two or three relevant specialties may be arranged. The scope and fee are agreed first. This is optional and not a prerequisite for every appointment. If you are considering it, ask what questions it will answer and what records it requires.
How to prepare your questions and what to do next
Write down the questions you want the MDT to answer, and send them with your records. A short list is more useful than a long file. Include: what the pathology and marker records show, what treatment has already been given, whether fertility has been addressed, what further treatment is proposed, and what remains uncertain. Ask the hospital to respond in writing so you can review it with your local doctor.
Do not delay necessary local care while you wait for an overseas reply. If your symptoms worsen, seek care where you are. An overseas enquiry is a planning step, not a substitute for urgent assessment.
If you want help organising a records-based review or a specialist appointment, you can start with a free initial enquiry. Our team checks the available diagnosis, records and your main question, identifies missing information and suggests the relevant next step. This is not a diagnosis or a promise of acceptance. You can share a brief summary first and send records after contact. For more on the procedure itself, see the testicular cancer surgery reference.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.